The current regulation of new pharmaceuticals is inefficient because it demands arbitrary amounts of information, the type of information demanded is not relevant to decision-makers and the same standards of evidence are applied across different technologies. Bayesian decision theory and an analysis
Peptoids—A New Approach to the Development of Pharmaceuticals
✍ Scribed by Prof. Dr. Horst Kessler
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 182 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0044-8249
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The rate at which we now produce, test, and warehouse new compound structures in the Discovery process strains our ability to evaluate and comprehend the information that results [Fayyad U. Database Programming and Design 1998;11(3):24]. With the advent of robotic systems and specialized software to
The controversial move toward the development of a consensus on evidencebased or empirically supported therapies may be seen as an international crisis facing psychotherapists. Researchers long have complained that practicing therapists all too often continue to guide what they do therapeutically on